Strategic Blueprint LLC decreased its stake in ARK Genomic Revolution ETF (BATS:ARKG – Free Report) by 9.1% in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 21,479 shares of the company’s stock after selling 2,148 shares during the quarter. Strategic Blueprint […]
McGuire Investment Group LLC raised its stake in shares of ARK Genomic Revolution ETF (BATS:ARKG – Free Report) by 91.0% during the fourth quarter, HoldingsChannel reports. The fund owned 20,558 shares of the company’s stock after acquiring an additional 9,792 shares during the quarter. McGuire Investment Group LLC’s holdings in ARK Genomic Revolution ETF were […]
Prudential PLC lowered its position in shares of ARK Genomic Revolution ETF (BATS:ARKG – Free Report) by 5.0% during the third quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 117,370 shares of the company’s stock after selling 6,200 shares during the quarter. Prudential PLC owned […]
Stephens Consulting LLC bought a new position in ARK Genomic Revolution ETF (BATS:ARKG – Free Report) in the third quarter, according to the company in its most recent 13F filing with the SEC. The fund bought 1,000 shares of the company’s stock, valued at approximately $28,000. A number of other hedge funds also recently bought […]
Stephens Consulting LLC acquired a new stake in ARK Genomic Revolution ETF (BATS:ARKG – Free Report) during the 3rd quarter, HoldingsChannel.com reports. The fund acquired 1,000 shares of the company’s stock, valued at approximately $28,000. Several other hedge funds have also modified their holdings of the stock. Wells Fargo & Company MN raised its stake […]